IOVS AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:5106-5115.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0322
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harhaj, N. S.
Right arrow Articles by Antonetti, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harhaj, N. S.
Right arrow Articles by Antonetti, D. A.

VEGF Activation of Protein Kinase C Stimulates Occludin Phosphorylation and Contributes to Endothelial Permeability

Nicole S. Harhaj,1,2 Edward A. Felinski,1 Ellen B. Wolpert,3 Jeffrey M. Sundstrom,1 Thomas W. Gardner,2 and David A. Antonetti1,2

1From the Departments of Cellular and Molecular Physiology and 3Ophthalmology, Penn State University College of Medicine, Hershey, Pennsylvania.

PURPOSE. VEGF is a potent permeabilizing factor that contributes to the pathogenesis of diabetic retinopathy and brain tumors. VEGF-induced vascular permeability in vivo and in cell culture requires PKC activity, but the mechanism by which PKC regulates barrier properties remains unknown. This study was conducted to examine how VEGF and diabetes alter occludin phosphorylation and endothelial cell permeability.

METHODS. Chemical PKC inhibitors and activators were used to treat primary retinal endothelial cells in culture. In vitro kinase assays and Western blot analysis of two-dimensional (2D) and one-dimensional (1D) gel retardation assays were used to analyze occludin phosphorylation. Endothelial cell permeability was determined by measuring the flux of 70-kDa dextran through a cell monolayer in culture. Exogenous expression of a dominant negative PKCßII mutant (S217A) was used to assess the PKC dependence of VEGF-induced occludin phosphorylation and endothelial permeability. Occludin phosphorylation was also determined in retinas of streptozotocin-induced diabetic rats.

RESULTS. VEGF stimulated the phosphorylation of occludin in primary retinal endothelial cells. Chemical inhibitors of PKC activity blocked the VEGF-induced increase in occludin phosphorylation, as assessed by 2D gel and gel retardation in Western blot analysis, and blocked part of the VEGF-induced monolayer permeability to 70-kDa dextran. Expression of a dominant negative PKCßII mutant blocked VEGF-induced occludin phosphorylation and endothelial permeability. Finally, elevated occludin phosphorylation was observed in the retina of diabetic animals.

CONCLUSIONS. These results strongly suggest that VEGF-induced endothelial permeability requires PKC-dependent phosphorylation of occludin. Regulation of PKC activity and tight junction protein modifications may have therapeutic implications for treatment of diabetic retinopathy and brain tumors.




This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
G. Davuluri, V. Espina, E. F. Petricoin III, M. Ross, J. Deng, L. A. Liotta, and B. M. Glaser
Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD: A New Class of Biomarkers in the Vitreous With Potential for Predicting the Treatment Timing and Monitoring Response
Arch Ophthalmol, May 1, 2009; 127(5): 613 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Rodewald, D. Herr, W.C. Duncan, H.M. Fraser, G. Hack, R. Konrad, F. Gagsteiger, R. Kreienberg, and C. Wulff
Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability
Hum. Reprod., May 1, 2009; 24(5): 1191 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. D. Kawedia, M. Jiang, A. Kulkarni, H. E. Waechter, K. S. Matlin, G. M. Pauletti, and A. G. Menon
The Protein Kinase A Pathway Contributes to Hg2+-Induced Alterations in Phosphorylation and Subcellular Distribution of Occludin Associated with Increased Tight Junction Permeability of Salivary Epithelial Cell Monolayers
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 829 - 837.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. Navaratna, G. Menicucci, J. Maestas, R. Srinivasan, P. McGuire, and A. Das
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes
FASEB J, September 1, 2008; 22(9): 3310 - 3317.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
H Deissler, H Deissler, S Lang, and G E Lang
VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells
Br. J. Ophthalmol., June 1, 2008; 92(6): 839 - 843.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Ruiz-Ederra and A. S. Verkman
Aquaporin-1 Independent Microvessel Proliferation in a Neonatal Mouse Model of Oxygen-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4802 - 4810.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology